EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population

Samir Al Bashir, Mohammed S Alorjani iD, Khalid Kheirallah iD, Mohammad Al Hamad iD, Husam K Haddad iD, Ahmad Al-Dwairy, Baha A Bani-Fawwaz, Najla Aldaoud iD, Omar Halalsheh, Saddam Amawi iD, Ismail I Matalka

Medicina · 2024

DOI: 10.3390/medicina60010174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Samir Al Bashir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan. Hauptthemen laut MEDLINE: Trypsin Inhibitor, Kazal Pancreatic, Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Support Fund, Scientific Research and Innovation Support Fund, Ministry of Higher Education, and Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Prognostic biomarkers in prostate cancer (PCa) include PTEN, ERG, SPINK1, and TFF3. Their relationships and patterns of expression in PCa in developing countries, including Jordan, have not yet been investigated. Materials and Methods: A tissue microarray (TMA) of PCa patients was taken from paraffin-embedded tissue blocks for 130 patients. PTEN, ERG, SPINK1, and TFF3 expression profiles were examined using immunohistochemistry (IHC) and correlated with each other and other clinicopathological factors.

Results

PTEN loss of any degree was observed in 42.9% of PCa cases. ERG and TFF3 were expressed in 59.3% and 46.5% of PCa cases, respectively. SPINK1 expression was observed in 6 out of 104 PCa cases (5.4%). Among all PCa cases (n = 104), 3.8% (n = 4) showed SPINK1+/ERG+ phenotype, 1.9% (n = 2) showed SPINK1+/ERG- phenotype, 56.7% (n = 59) showed SPINK1-/ERG+ phenotype, and 37.5% showed SPINK1-/ERG- phenotype (n = 39). Among ERG positive cases (n = 63), 6.3% were SPINK1 positive. Among SPINK1 positive cases (n = 6), 66.7% were ERG positive. SPINK1 expression was predominantly observed in a subgroup of cancers that expressed TFF3 (6/6). Additionally, a statistically significant loss of PTEN expression was observed from Gleason Score 6 (GS6) (Grade Group 1 (GG1)) to GS9-10 (GG5); (p-value 0.019).

Conclusions

This is the first study to look at the status of the PTEN, ERG, SPINK1, and TFF3 genes in a Jordanian Arab population. Loss of PTEN has been linked to more aggressive prostate cancer with high GSs/GGs. SPINK1 expression was predominantly observed in a subgroup of cancers that expressed TFF3. Our results call for screening these biomarkers for grading and molecular subtyping of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypsin Inhibitor, Kazal PancreaticProstatic NeoplasmsMaleHumansJordanArabsBiomarkersTranscriptional Regulator ERGTrefoil Factor-3PTEN Phosphohydrolase

Stichwörter der Autor:innen

ERGPTENSPINK1TFF3prostate cancer

Substanzen

Trypsin Inhibitor, Kazal PancreaticBiomarkersERG protein, humanTranscriptional Regulator ERGTFF3 protein, humanTrefoil Factor-3PTEN protein, humanPTEN PhosphohydrolaseSPINK1 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  • Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  • Department of Pathology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
  • Department of Pathology and Laboratory Medicine, Ministry of Health, Amman 11118, Jordan.
  • Medstar-Georgetown Washington Hospital Center, Georgetown University, Washington, DC 20057, USA.
  • Gastroenterology and Hepatology Department, Adventhealth, Orlando, FL 32804, USA.

ORCID-Profile: Mohammed S Alorjani, Khalid Kheirallah, Mohammad Al Hamad, Husam K Haddad, Najla Aldaoud, Saddam Amawi

Förderung

  • Scientific Research Support Fund
  • Scientific Research and Innovation Support Fund, Ministry of Higher Education, and Scientific Research

Zitieren

APA

Al Bashir, S., Alorjani, M. S., Kheirallah, K., Al Hamad, M., Haddad, H. K., Al-Dwairy, A., Bani-Fawwaz, B. A., Aldaoud, N., Halalsheh, O., Amawi, S., & Matalka, I. I. (2024). PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population. Medicina. https://doi.org/10.3390/medicina60010174

Vancouver

Al Bashir S, Alorjani MS, Kheirallah K, Al Hamad M, Haddad HK, Al-Dwairy A, et al. PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population. Medicina. 2024. doi:10.3390/medicina60010174

BibTeX
@article{AlBashir2024,
  author = {Al Bashir, Samir and Alorjani, Mohammed S and Kheirallah, Khalid and Al Hamad, Mohammad and Haddad, Husam K and Al-Dwairy, Ahmad and Bani-Fawwaz, Baha A and Aldaoud, Najla and Halalsheh, Omar and Amawi, Saddam and Matalka, Ismail I},
  title = {PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60010174}
}
Kostenlos starten →